Contact Us

New Stories

• Island expands portfolio with the acquisition of antiviral

  July 10, 2025 - - Latest News

• Orthocell announces first US Remplir sales revenue

  July 10, 2025 - - Latest News

• Race secures ethics approvals for Phase 1 trial at two Hong Kong hospitals

  July 10, 2025 - - Latest News

• Imagion reports positive feedback from FDA for HER2 breast cancer trial

  July 10, 2025 - - Latest News

• Neurizon says FDA provides positive feedback on strategy to lift clinical hold for NUZ-001

  July 10, 2025 - - Latest News

• WHO grants official INN for Syntara’s clinical development asset SNT-5505

  July 8, 2025 - - Latest News

• AusBiotech welcomes 27 new members in first half of 2025

  July 8, 2025 - - AusBiotech